Close X
Thursday, November 28, 2024
ADVT 
National

EU regulator advises AstraZeneca's COVID drug be cleared

Darpan News Desk The Canadian Press, 24 Mar, 2022 12:41 PM
  • EU regulator advises AstraZeneca's COVID drug be cleared

LONDON (AP) — The European Union's drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus.

The European Medicines Agency said in a statement that it was advising the use of the new drug, sold as Evusheld, in people age 12 and over before they were exposed to COVID-19, to prevent future infections.

It is now up to the EU's executive arm, the European Commission, to officially authorize the drug.

The U.S. Food and Drug Administration cleared the medication in December for people with serious health problems or allergies who can’t get adequate protection from vaccination. Britain authorized the use of Evusheld last week.

“When the antibodies in Evusheld attach to the spike protein, the virus cannot enter the cells to multiply and is unable to cause COVID-19 infection,” the EMA said. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated to last at least six months.

EMA said the drug's side effects were mostly mild, with some people reporting reactions at the injection point. The agency noted that research was done before the emergence of the hugely infectious omicron variant and said that it was evaluating data to determine if a different dose might be needed.

Although antibody drugs have been a standard treatment for treating COVID-19 infections for more than a year, AstraZeneca's is the first intended for long-term prevention against COVID-19 infection rather than as a short-term treatment.

People who could benefit from the antibody drug include cancer patients, organ transplant recipients and individuals taking immune-suppressing drugs for conditions like rheumatoid arthritis.

___

 

MORE National ARTICLES

PBO: Inflation boosts spending on seniors' aid

PBO: Inflation boosts spending on seniors' aid
Federal health transfers are calculated to grow by at least three per cent each year, but the budget office says that health-care transfers are set to rise by almost five per cent year-over-year.

PBO: Inflation boosts spending on seniors' aid

Nanaimo, B.C., couple lose $400,000 in scam

Nanaimo, B.C., couple lose $400,000 in scam
A statement from police says the couple, who are both in their late 80s, were contacted by phone early last year. They were told they had won $18.5 million and a Mercedes-Benz but would have to pay administrative fees in order to collect.

Nanaimo, B.C., couple lose $400,000 in scam

Health workers emergency summit warns of burnout

Health workers emergency summit warns of burnout
Health workers have now endured two difficult years of pandemic conditions, leading to serious burnout across nearly all sectors of the health-care system.

Health workers emergency summit warns of burnout

Trudeau, Polish leaders, discuss refugee crisis

Trudeau, Polish leaders, discuss refugee crisis
Prime Minister Justin Trudeau is in Poland today meeting with Duda and Poland's Prime Minister Mateusz Morawiecki as an estimated 100,000 Ukrainian refugees pour into Poland every day.

Trudeau, Polish leaders, discuss refugee crisis

Charest to launch Conservative leadership bid

Charest to launch Conservative leadership bid
Winning is something Conservatives want to see after three back-to-back losses to Liberal Prime Minister Justin Trudeau, whose minority of seats in the House of Commons means an election could be triggered at any point.

Charest to launch Conservative leadership bid

B.C. set to update COVID-19 situation

B.C. set to update COVID-19 situation
Dr. Bonnie Henry said last week the province was better positioned to consider removing pandemic restrictions before students begin spring break on Monday.

B.C. set to update COVID-19 situation